Skip to content

Study Details

Testing the Drug VE202 in Adults with Mild-to-Moderate Ulcerative Colitis

(IRB#: IRB_00168499)

Mild-to-Moderate Ulcerative Colitis (UC) causes inflammation of the large intestine (colon). This study will test a drug called VE202 to treat adults with this disease. The study wants to see if the drug will help people with the disease and is safe. People in this study will be randomly chosen to be treated with the study drug VE202 or a placebo. The drug and placebo are taken as a swallowed pill. The placebo does not have the treatment. Later in the study, people on the placebo are switched to the drug, and people on the drug are switched to the placebo. Participation in the study requires up to 2.5 years. Medical tests will be done during the study to track the health of participants.


  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18 to 75 years old
  • Confirmed diagnosis of Ulcerative Colitis
  • Active or moderate Ulcerative Colitis
  • Willing to use specific birth control during study participation
  • Attend in person at the study clinic

Exclusion Criteria

  • Pregnant or breastfeeding
  • Active infection of the body
  • Any other active chronic disease that affects participation
  • History of drug or alcohol abuse

Will I be paid for my time?


For more information contact:

Julie Will


IRB#: IRB_00168499

PI: John Valentine


Approval Date: 2023-10-11 06:00:00

Specialties: Gastroenterology

Last Updated: 6/8/23